Sort   by:  
 Page size 
UnknownRisk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.
Not available
S-EPMC6306365 | biostudies-literature
UnknownAxicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial.
Not available
S-EPMC9018426 | biostudies-literature
UnknownMfge8 attenuates human gastric antrum smooth muscle contractions.
Not available
S-EPMC8332633 | biostudies-literature
UnknownRelaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers.
Not available
S-EPMC9789945 | biostudies-literature
UnknownDynamics of Intraprocedural Dominant Frequency Identifies Ablation Outcome in Persistent Atrial Fibrillation.
Not available
S-EPMC8546232 | biostudies-literature
UnknownAvelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial.
Not available
S-EPMC8525219 | biostudies-literature
UnknownPrevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection.
Not available
S-EPMC8279935 | biostudies-literature
UnknownMosunetuzumab is effective and well tolerated in older patients with relapsed/refractory follicular lymphoma: Subgroup analysis of a phase I/II study.
Not available
S-EPMC12819098 | biostudies-literature
UnknownSwiss National Registry on Catheter Ablation Procedures: Changing Trends over the Last 20 Years.
Not available
S-EPMC8304673 | biostudies-literature
UnknownCentral American and Caribbean Consensus Document for the Optimal Management of Oral Anticoagulation in Patients with Non-Valvular Atrial Fibrillation Endorsed by the Central American and Caribbean Society of Arterial Hypertension and Cardiovascular Prevention.
Not available
S-EPMC10816126 | biostudies-literature
Sort   by:  
 Page size